RE-BVS – Piemonte Repository

Sfoglia per AUTORE
MASSAIA M
Collezione AO Cuneo

Items : 21

Anti-CD20 maintenance strategies to face the challenge of COVID-19 pandemic in follicular lymphoma: results from the R-FolSTOP multicentre Italian study. in Annals of hematology / Ann Hematol. 2025 Mar 12. doi: 10.1007/s00277-025-06295-0.

2025
AO Cuneo
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Massaia M; Castellino C; Galimberti S; Ratotti S; Conconi A; Annibali O; Farina L; Margiotta-Casaluci G; Meli E; Anastasia A; Bozzoli V; Mecacci B; Bigliardi S; Merli M; Cocito F; Marchesi F; Fanelli F; Perrone T; Vanazzi A; Clerico M; Nicoli P; Boccomini C; Comba L; Bertolotti L; Castellino A;

Management of chimeric antigen receptor T-cell-related toxicity of a patient affected by cytokine release syndrome and immune effector cell-associated neurotoxicity syndrome, followed by an intestinal perforation: a case report. in Journal of medical case reports / J Med Case Rep. 2025 Jan 20;19(1):27. doi: 10.1186/s13256-024-04905-5.

2025
AO Cuneo

Menardi G; Castellino A; Castellino C; Bersia ME; Grande E; Fraternali G; Massaia M; Fruttero C; Menardi G; Castellino A; Castellino C; Bersia ME; Grande E; Fraternali G; Massaia M; Fruttero C;

End of induction [(18)F]FDG PET is prognostic for progression-free survival and overall survival in follicular lymphoma patients enrolled in the FOLL12 trial. in European journal of nuclear medicine and molecular imaging / Eur J Nucl Med Mol Imaging. 2024 Sep;51(11):3311-3321. doi: 10.1007/s00259-024-06765-z. Epub 2024 Ma

2024
AOU Alessandria
AO Cuneo

Usai SV; Vitolo U; Falcinelli F; Gini G; Galimberti S; Roti G; Mannina D; Musto P; Conconi A; Massaia M; Bari A; Califano C; Arcari A; Chiarenza A; Pavone V; Bolis SAM; Bianchi B; Tosi P; Musuraca G; Ladetto M; Barbieri E; Monaco L; Franceschetto A; Peano S; Durmo R; Marcheselli L; Bergesio F; Fallanca F; Chauvie S; et alii...

Surgery and Prophylaxis with Susoctocog-Alfa in Acquired Hemophilia: Case Series and Literature Review. in Journal of clinical medicine / J Clin Med. 2023 Jul 10;12(14):4590. doi: 10.3390/jcm12144590.

2023
AO Cuneo
AOU Città della Salute di Torino

Bruno B; Porreca A; Grimaldi D; Massaia M; Valpreda A; Dainese C; Valeri F; Bardetta M; Sella C; Borchiellini A;

SARS-CoV-2 infection in patients with chronic lymphocytic leukemia: The Italian Hematology Alliance on COVID-19 cohort. in Hematological oncology / Hematol Oncol. 2023 Feb;41(1):128-138. doi: 10.1002/hon.3092. Epub 2022 Oct 25.

2023
AOU Alessandria
AO Cuneo
AOU Città della Salute di Torino

Visco C; Corradini P; Passamonti F; Bertù L; Guidetti A; Gherlinzoni F; Pagano L; Visani G; Federici AB; Tisi MC; Cudillo L; Galimberti S; Cilloni D; Della Porta MG; Coviello E; Mohamed S; Mauro FR; Gentile M; Gambacorti-Passerini C; Bocchia M; Massaia M; Billio A; Fracchiolla NS; Marchesi F; Scattolin A; Trentin L; Cattaneo C; Derenzini E; Cavo M; et alii...

Improved efficiency of daratumumab treatment of multiple myeloma adopting the subcutaneous route: A micro-costing analysis in three Italian hematology centers. in Cancer medicine / Cancer Med. 2023 Dec;12(23):21480-21489. doi: 10.1002/cam4.6699. Epub 2023 Nov 9.

2023
AO Cuneo

Pradelli L; Massaia M; Todisco E; Gherlinzoni F; Furlan A; La Targia M; Grande E; Tripoli IE; Occhipinti F; Comello F; Iannello F; Bellucci S;

High rate of durable responses with undetectable minimal residual disease with front-line venetoclax and rituximab in young, fit patients with chronic lymphocytic leukemia and an adverse biological profile: results of the GIMEMA phase II LLC1518 - VERITAS study. in Haematologica / Haematologica. 2023 Aug 1;108(8):2091-2100. doi: 10.3324/haematol.2022.282116.

2023
AOU Alessandria
AO Cuneo
AO Ordine Mauriziano
AOU Città della Salute di Torino

Fazi P; Vignetti M; Guarini A; Cuneo A; Piciocchi A; De Propris MS; Nanni M; Del Giudice I; Neri A; De Novi LA; Albano F; Vitale C; Visentin A; Pietrasanta D; Mattiello V; Molinari MC; Liberati AM; Giordano A; Patrizi VB; Gottardi D; Galieni P; Deodato M; Arcari A; Musuraca G; Tani M; Levato L; Marchetti M; Massaia M; Rigolin GM; et alii...

Induction of robust humoral immunity against SARS-CoV-2 after vaccine administration in previously infected haematological cancer patients. in British journal of haematology / Br J Haematol. 2022 Nov;199(3):463-467. doi: 10.1111/bjh.18429. Epub 2022 Sep 5.

2022
AOU Alessandria
AO Cuneo

Massaia M; Ladetto M; Pistello M; Lai M; Rapezzi D; Marchetti M; Gaidano V; Ucciero MAM; Mahmoud AM; Patriarca A; Ferrante D; De Andrea M; Martuscelli L; Griffante G; Borgogna C; Bruna R; Gaidano G; Gariglio M; Borgogna C; Bruna R; Griffante G; Martuscelli L; De Andrea M; Ferrante D; Patriarca A; Mahmoud AM; Ucciero MAM; Gaidano V; Marchetti M; et alii...

ADAMTS13 Autoantibodies and Burden of Care in Immune Thrombotic Thrombocytopenic purpura: New Evidence and Future Implications. in Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis / Clin Appl Thromb Hemost. 2022 Jan-Dec;28:10760296221125785. doi: 10.1177/10760296221125785.

2022
AO Cuneo
AO Ordine Mauriziano
AOU Città della Salute di Torino

Massaia M; Bruno B; Borchiellini A; Porreca A; Montaruli B; Sivera P; Pizzo E; Valpreda A; Valeri F; Dainese C;

Patterns of neutralizing humoral response to SARS-CoV-2 infection among hematologic malignancy patients reveal a robust immune response in anti-cancer therapy-naive patients. in Blood cancer journal / Blood Cancer J. 2022 Jan 18;12(1):8. doi: 10.1038/s41408-022-00608-6.

2022
AOU Alessandria
AO Cuneo

Gariglio M; Massaia M; Gaidano G; Ladetto M; Lai M; Pistello M; Rapezzi D; Marchetti M; Gaidano V; Mahmoud AM; Patriarca A; Ferrante D; Griffante G; Martuscelli L; De Andrea M; Borgogna C; Bruna R;

A prognostic model for patients with lymphoma and COVID-19: a multicentre cohort study. in Blood advances / Blood Adv. 2022 Jan 11;6(1):327-338. doi: 10.1182/bloodadvances.2021005691.

2022
AOU Alessandria
AO Cuneo
AOU Città della Salute di Torino

Merli F; Krampera M; Corradini P; Passamonti F; Lanza F; Candoni A; Conconi A; Tosi P; Vallisa D; Venditti A; Selleri C; La Barbera EO; Gambacorti-Passerini C; Visani G; Rigacci L; Armiento D; Cilloni D; Corso A; Gherlinzoni F; Tafuri A; Galimberti S; Bocchia M; Cardinali V; Turrini M; Trentin L; Della Porta M; Scattolin A; Tisi MC; Cuneo A; et alii...

Secondary infections worsen the outcome of COVID-19 in patients with hematological malignancies: A report from the ITA-HEMA-COV. in Hematological oncology / Hematol Oncol. 2022 Dec;40(5):846-856. doi: 10.1002/hon.3048. Epub 2022 Aug 12.

2022
AO Cuneo
AOU Città della Salute di Torino

Corradini P; Passamonti F; Antonio Grossi P; Bruno R; Pagano L; Luppi M; Busca A; Giuliani N; Corso A; Mohamed S; Tosi P; Giovanni Della Porta M; Lanza F; Rigacci L; Massimo Lemoli R; Venditti A; Tafuri A; Billio A; Gentile M; Falini B; Turrini M; Chiara Tisi M; Morotti A; Coviello E; Trentin L; Bocchia M; Galimberti S; Cuneo A; Musto P; et alii...

How COVID-19 pandemic changed our attitude to venetoclax-based treatment in chronic lymphocytic leukemia. in Leukemia & lymphoma / Leuk Lymphoma. 2022 Aug;63(8):1985-1988. doi: 10.1080/10428194.2022.2053532. Epub 2022 Mar 27.

2022
AO Cuneo
AOU Città della Salute di Torino

Tedeschi A; Montillo M; Zamprogna G; Marinoni S; Ferrario A; Tani M; Varettoni M; Borella C; Ferrarini I; Sanna A; Motta M; Ibatici A; Orsucci L; Massaia M; Vitale C; Vanazzi A; Mauro FR; Quaresmini G; Visentin A; Reda G; Murru R; Laurenti L; Sportoletti P; Frustaci AM; Deodato M;

Atypical Chronic Myeloid Leukemia: New Developments from Molecular Diagnosis to Treatment. in Medicina (Kaunas, Lithuania) / Medicina (Kaunas). 2021 Oct 14;57(10):1104. doi: 10.3390/medicina57101104.

2021
AO Cuneo

Massaia M; Rapezzi D; Santambrogio E; Castellino A;

COVID-19 elicits an impaired antibody response against SARS-CoV-2 in patients with haematological malignancies. in British journal of haematology / Br J Haematol. 2021 Nov;195(3):371-377. doi: 10.1111/bjh.17704. Epub 2021 Jul 16.

2021
AOU Alessandria
AO Cuneo
AOU Città della Salute di Torino

Corradini P; Pagano L; Grossi PA; Bertù L; Zaja F; Petrucci L; Lanza F; Musto P; Visani G; Mina R; La Barbera EO; Cattaneo C; Galimberti S; Candoni A; Krampera M; Luppi M; Cardinali V; Armiento D; Bocchia M; Marchesi F; Fracchiolla N; Pinto A; Tafuri A; Arcaini L; Ladetto M; Massaia M; Busca A; Venditti A; Farina F; et alii...

Diagnosis of maternal Hodgkin lymphoma following abnormal findings at noninvasive prenatal screening test (NIPT): Report of two cases. in Clinical case reports / Clin Case Rep. 2021 Jan 13;9(3):1066-1071. doi: 10.1002/ccr3.3593. eCollection 2021 Mar.

2021
AO Cuneo
ASL Cuneo 1
AOU Città della Salute di Torino

Massaia M; Bonferroni M; Grasso M; Rapezzi D; Zonta A; Priotto R; Mattei D; Mordini N; Foglietta M; Masturzo B; Celeghini I; Signorile AF; Giacchello R; Grosso E; Sorasio R; Castellino A; Castellino C; Elba S;

Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study. in The Lancet. Haematology / Lancet Haematol. 2020 Oct;7(10):e737-e745. doi: 10.1016/S2352-3026(20)30251-9. Epub 2020 Aug 13.

2020
AOU Alessandria
AO Cuneo
AOU Città della Salute di Torino

Corradini P; Pagano L; Bertù L; Corrao G; Grossi PA; Franchi M; Oberti M; Zappasodi P; Visco C; Armiento D; Pane F; Galieni P; Rigacci L; Pinto A; Fava C; Candoni A; Venditti A; Federici AB; Musto P; Marchesi F; Gentile M; Bocchia M; Olivieri A; Di Renzo N; Ferrandina C; Ortu La Barbera E; Selleri C; Scattolin AM; Luppi M; et alii...

Immunoglobulin M (IgM) multiple myeloma versus Waldenström macroglobulinemia: diagnostic challenges and therapeutic options: two case reports. in Journal of medical case reports / J Med Case Rep. 2020 Jun 22;14(1):75. doi: 10.1186/s13256-020-02380-2.

2020
AO Cuneo

Giordano F; Grasso M; Celeghini I; Rapezzi D; Foglietta M; Mordini N; Drandi D; Strola G; Mattei D; Bonferroni M; Castellino C; Soriasio R; Castellino A; Elba S; Fraternali Orcioni G; Massaia M;

HIF-1? is over-expressed in leukemic cells from TP53-disrupted patients and is a promising therapeutic target in chronic lymphocytic leukemia. in Haematologica / Haematologica. 2020 Apr;105(4):1042-1054. doi: 10.3324/haematol.2019.217430. Epub 2019 Jul 9.

2020
ASL Asti
AO Cuneo
AOU Città della Salute di Torino

Coscia M; Foà R; Massaia M; Gaidano G; Bernardi R; Gattei V; Zenz T; Mauro FR; Del Poeta G; Laurenti L; Omedè P; Kodipad AA; Marchetti M; Bonello L; Magliulo D; Bo MD; Pozzato G; Rossi D; Bomben R; Riganti C; Salvetti C; Kopecka J; Todaro M; Vitale C; Griggio V; Boccadoro M;

A Score-Based Approach to (18)F-FDG PET Images as a Tool to Describe Metabolic Predictors of Myocardial Doxorubicin Susceptibility. in Diagnostics (Basel, Switzerland) / Diagnostics (Basel). 2017 Oct 26;7(4):57. doi: 10.3390/diagnostics7040057.

2017
AO Cuneo

Bauckneht M; Morbelli S; Fiz F; Ferrarazzo G; Piva R; Nieri A; Sarocchi M; Spallarossa P; Canepari ME; Arboscello E; Bellodi A; Massaia M; Gallamini A; Bruzzi P; Marini C; Sambuceti G;

Bendamustine and subcutaneous alemtuzumab combination is an effective treatment in relapsed/refractory chronic lymphocytic leukemia patients. in Haematologica / Haematologica. 2014 Sep;99(9):e159-61. doi: 10.3324/haematol.2014.106740. Epub 2014 Jun 27.

2014
AO Cuneo

Montillo M; Tedeschi A; Gaidano G; Coscia M; Petrizzi VB; Orlandi E; Cascavilla N; Ghia P; Motta M; Gallamini A; Frustaci AM; Rossi D; De Paoli L; Nichelatti M; Morra E; Massaia M;